SynthesisFuture oncology (London, England)2024
Comparative efficacy and safety of eribulin versus paclitaxel in breast cancer: a systematic review and meta-analysis.
Jialin Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.